https://doi.org/10.4081/reumatismo.2006.59

Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

Vol. 58 No. 1 (2006)
Abstract Views: 870
PDF: 849
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Giuseppe D'Alessandro
office@pagepress.org
Maria Rosaria Bianco
Spiridon Politis
Celestino Ferrandina
Giuseppe Rossi
Emanuele Altomare
Anti TNF-a drugs seem to be the new frontier of Rheumatoid Arthritis (RA) therapy. The association infliximab methotrexate has been approved for the treatment of RA not responding to the classic therapy, but the short clinical experience in using antiTNF-a molecules brings to segnalation of new risks or adverse events. We describe a case of a patient, treated for many years with classic RA therapy, which developed a refractory anemia after treatment with association infliximab-methotrexate.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

D’Alessandro, G., Bianco, M. R., Politis, S., Ferrandina, C., Rossi, G., & Altomare, E. (2006). Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab. Reumatismo, 58(1), 59–61. https://doi.org/10.4081/reumatismo.2006.59

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.